Caspofungin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 to 2027

The global caspofungin market size was valued at US$ 480 Mn in 2019 and is expected to reach US$ 500 Mn by 2027. Rise in prevalence of candidiasis, increase in usage of echinocandins, surge in disposable income in the emerging countries, and rise in awareness among people about preventive measures of various microbial diseases are factors projected to propel the global market during the forecast period.

The report offers detailed segmentation of the global caspofungin market based on indication, distribution channel, and region. In terms of indication, the candidiasis segment is anticipated to account for large market share due to increase in applications of echinocandins in candidiasis and benefits of echinocandins over other antifungals. The benefits of echinocandins include low risk of drug-drug interactions, novel mechanism of action, and lesser adverse effects. Echinocandins demonstrate compelling activity against Candida species and are the preferred first-line therapy for patients with invasive candidiasis. It has been reported that more than 60% of candidemia patients receive echinocandin during therapy.

Hospital Pharmacies Segment to Account for Major Share

The hospital pharmacies segment is projected to account for leading share of the global market by 2027. Rise in prevalence of mycosis in the elderly population has increased the number of hospital visits. This in turn is likely to boost the growth of the segment.

North America Market to Expand at Rapid Pace

North America held major share of the global market in terms of revenue in 2019 and is projected to sustain its position during the forecast period. High awareness about latest health care technologies and higher purchasing power are attributed to the larger market share of the region. Favorable reimbursement policies in the region also enable patients to avail the best health care facilities. Europe is anticipated to be the second largest market in terms of share and revenue during the forecast period. Developed health care infrastructure in the region has helped patients undergoing therapies in covering their expenditure. Most health care providers in countries such as Germany, the U.K., and France provide full or partial coverage of costs related to treatment, medication, physicians cost, and tests depending on the patient’s insurance plan and income.

Merck & Co., Inc., Mylan N.V., and Fresenius SE & Co. KGaA to Lead Global Market

The report also provides profiles of leading players operating in the global caspofungin market. These include Teva Pharmaceutical Industries Ltd., Gland Pharma Limited, and Xellia Pharmaceuticals.

The report analyzes and forecasts the caspofungin market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2020 to 2027. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

This report first introduces the background of caspofungin, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major caspofungin companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of caspofungin upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of caspofungin and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global caspofungin market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the caspofungin market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of caspofungin market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Companies Mentioned in Report

The report also profiles major players in the global caspofungin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Xellia Pharmaceuticals, and Novartis AG.

The global caspofungin market has been segmented as follows:

Global Caspofungin Market, by Indication

• Candidiasis
• Thrush

Global Caspofungin Market, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Caspofungin Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Australia & New Zealand
  • Japan
  • China
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

• To analyze and study the global caspofungin capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
• Market value USD Million and volume Units Million data for each segment and sub-segment
• Focuses on the key caspofungin manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.